SCHEMBL18615440

SCHEMBL18615440

CC(C)(C)OC(=O)N[C@H]1CC[C@H](Oc2ccnc(N3CCOCC3)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.48
▸ CKS1B P61024 1/20 0.45
▸ SKP1 P63208 1/20 0.45
▸ SKP2 Q13309 1/20 0.45
▸ PIK3CA P42336 2/20 0.44
▸ EPHX2 P34913 3/20 0.43
▸ RAF1 P04049 1/20 0.43
▸ MAPK13 O15264 1/20 0.41
▸ LNPEP Q9UIQ6 1/20 0.41
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ BTK Q06187 1/20 0.40
▸ CACNB4 O00305 1/20 0.40
▸ CACNA1A O00555 1/20 0.40
▸ CACNA1G O43497 1/20 0.40
▸ CACNG3 O60359 1/20 0.40
▸ CACNA1F O60840 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNB3 P54284 1/20 0.40
▸ CACNA2D1 P54289 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18615424 0.85 CKS1B (0.47) LRRK2CKS1BSKP1SKP2RAF1
SCHEMBL18615459 0.83 CYP2C19 (0.47) CKS1BSKP1SKP2RAF1BTK
SCHEMBL18615747 0.81 CKS1B (0.43) LRRK2CKS1BSKP1SKP2JAK2
SCHEMBL18615436 0.80 EPHX2 (0.53) CKS1BSKP1SKP2EPHX2RAF1
SCHEMBL529587 0.77 CKS1B (0.56) CKS1BSKP1SKP2JAK2JAK1
SCHEMBL24011176 0.77 KDM1A (0.50) CKS1BSKP1SKP2EPHX2RAF1
SCHEMBL18615484 0.77 KDM1A (0.50) CKS1BSKP1SKP2EPHX2RAF1
SCHEMBL21279209 0.76 CACNB4 (0.39) CKS1BSKP1SKP2JAK2JAK1
SCHEMBL16079597 0.76 CACNB4 (0.39) CKS1BSKP1SKP2JAK2JAK1
SCHEMBL29338283 0.76 CKS1B (0.41) CKS1BSKP1SKP2PIK3CAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345893-B1 UREA DERIVATIVE AND USE THEREFOR TORAY INDUSTRIES (JP) 2019-10-30 — — EP disclosed
US-10280145-B2 Urea derivative and use therefor TORAY INDUSTRIES, INC. (JP) 2019-05-07 — — US disclosed
EP-3345893-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 — — EP disclosed
WO-2017038873-A1 UREA DERIVATIVE AND USE THEREFOR 東レ株式会社 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280145-B2 Urea derivative and use therefor UTS2R, DDR1, WEE1 LRRK2 268/4885CKS1B 1366/4885SKP1 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback